Gsk (GSK) Income towards Parent Company (2016 - 2025)
Historic Income towards Parent Company for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to $2.7 billion.
- Gsk's Income towards Parent Company rose 370357.56% to $2.7 billion in Q3 2025 from the same period last year, while for Dec 2025 it was $6.7 billion, marking a year-over-year increase of 1981.84%. This contributed to the annual value of $3.3 billion for FY2024, which is 4630.02% down from last year.
- According to the latest figures from Q3 2025, Gsk's Income towards Parent Company is $2.7 billion, which was up 370357.56% from $1.9 billion recorded in Q2 2025.
- In the past 5 years, Gsk's Income towards Parent Company ranged from a high of $12.8 billion in Q3 2022 and a low of -$75.4 million during Q3 2024
- Moreover, its 5-year median value for Income towards Parent Company was $1.9 billion (2025), whereas its average is $2.5 billion.
- As far as peak fluctuations go, Gsk's Income towards Parent Company crashed by 10406.38% in 2024, and later skyrocketed by 370357.56% in 2025.
- Over the past 5 years, Gsk's Income towards Parent Company (Quarter) stood at $1.0 billion in 2021, then soared by 206.69% to $3.1 billion in 2022, then increased by 24.82% to $3.9 billion in 2023, then decreased by 26.31% to $2.8 billion in 2024, then decreased by 4.65% to $2.7 billion in 2025.
- Its last three reported values are $2.7 billion in Q3 2025, $1.9 billion for Q2 2025, and $2.0 billion during Q1 2025.